Broncus Medical (02216.HK) Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing.
/PRNewswire/ -- On March 29, 2022, Broncus Medical (02216.HK), the leader in precision interventional treatment for lung diseases in China, announced its...
United States United Kingdom Asia Pacific United Family Healthcare Group Shandong Public Health Clinical Center Healium Medical Ltd
Source: prnewswire.com